Federal regulator hauls huge drug middlemen into court over insulin prices
The government’s antitrust watchdog on Friday sued three massive health conglomerates, accusing their drug middlemen of forcing insulin prices to skyrocket since 2012. The Federal Trade Commission claims that the middlemen — known as pharmacy benefit managers,
19hon MSN
The FTC is warning Ohioans that consumer scams are on the rise, and unfortunately, scammers are growing more sophisticated in laying their traps.
As the youngest head of the Federal Trade Commission in history, Lina Khan has rallied against Big Tech, challenged deceptive ...
Lawmakers revised the Horseracing Integrity and Safety Act in 2022, giving the Federal Trade Commission authority to overrule ...
Cigna Group’s Express Scripts sued the US Federal Trade Commission over a recent report that the company said demonizes ...
Headquartered in North St. Louis County, Express Scripts, a subsidiary of The Cigna Group, is demanding the FTC retract a ...
The federal government is suing some pharmacy benefit managers over a system of drug rebates that regulators say has made the ...
Legal regimes are shifting, including in the intellectual property world as businesses increasingly seek the protection of trade secrets rather ...
The Federal Trade Commission took action Friday against the nation’s three largest pharmacy benefit managers, accusing the companies of artificially inflating insulin list prices that resulted ...
For the second time in a little more than a month, Ohio Attorney General Dave Yost is backing Cincinnati-based grocery giant ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback